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Introduction. Health care Workers are exposed to infectious dis-
eases more than the general population. Many of these infections 
are preventable by vaccination. The objective in this study is to 
investigate whether, how, and which vaccination underwent Sar-
dinia Health Care Workers (HCWs) and the variability of policies 
in different Hospital Health Managements of the whole region.
Methods. In March 2013, we enrolled the Hospital Health Man-
agement of all the 32 Sardinia hospitals. We investigate on immu-
nity against vaccine-preventable diseases and education cam-
paigns about recommended vaccinations for HCWs. Flu, hepati-
tis B, measles-mumps-rubella, varicella and tuberculosis were the 
objects of our research.
Results. In most of the hospitals, influenza vaccination coverage 
among HCWs is less than 6%. Hepatitis B antibody assay was 
performed in all the respondent hospitals but only 14 had avail-
able data as collected electronically. Most of the hospitals did not 
perform serological tests for the evaluation of antibodies against 
Varicella, Measles, Mumps and Rubella in their HCWs. In 30 hos-
pitals Mantoux test was replaced or integrated by “in vitro” test 
for health surveillance protocols.
Conclusions. This method produced a large amount of data in 
small time and at a low cost. Sending back data to respective Hos-
pital Health Management (HHM) we took a step towards greater 
awareness of the issue of biological risks of HCWs and of vaccine 
coverage.
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Summary
Introduction
Health care workers (HCWs) are defined as persons 
working in health-care milieu having potential exposure 
to patients and to infectious materials; they are exposed 
to infectious diseases more than the general population 
although many of these infections are preventable by 
vaccination. When infected, HCWs may transmit the in-
fection to patients or colleagues [1].
Outbreaks due to vaccine-preventable diseases in health 
care facilities are often associated with serious morbid-
ity and mortality among patients, disruption of health-
care services, and high costs for the National Health 
Service [2].
Immunization of HCWs is a major infection prevention 
measure [3] to protect HCWs and, indirectly, the patients 
who may not be naturally immunized or vaccinated [4]. 
Vaccination is a very effective tool to promote safety 
within health care facilities for both HCWs and patients. 
Nevertheless, inadequate coverage of HCWs against 
vaccine-preventable diseases is a global problem [5].
In Italy, vaccination policies for HCWs are based – on 
one hand – on the “National Vaccination Plan” [6] which 
reinforces the recommendation to vaccinate HCWs 
against selected vaccine preventable diseases. On the 
other hand, the Italian Legislative Decree 81/08 reorgan-
izes and revises all the provisions regarding health and 
safety at work. In particular, the Decree ratifies the obli-
gation to the employers to provide vaccination to work-
ers exposed to biological risk and emphasizes the key 
role of the Occupational physician for assessing biologi-
cal risk, identifying and managing susceptible workers, 
and organizing and implementing vaccine campaigns. 
Therefore, employers and Occupational physicians have 
to manage vaccination activities within hospitals for 
their workers. In this sense, the following vaccinations 
are strongly recommended: anti-hepatitis B, anti-influ-
enza, anti-measles-mumps-rubella, anti-varicella and 
anti-pertussis. The Italian law has drastically limited the 
use of the anti-TB vaccination to very few categories of 
HCWs: those who are at high risk of exposure to mul-
ti-drug-resistant tubercular bacterial strains, and those 
who work in high-risk environments and – in the case of 
positive Mantoux Test – they cannot undergo preventive 
therapy because of clinical contraindications to the use 
of specific drugs. The aim of our study was to inves-
tigate  (1) whether, how, and which vaccination under-
went the Sardinia HCW’s; (2) the variability of policies 
and solutions in different Hospital Health Managements 
(HHM) of the whole region.
Consequently, an indirect aim was to raise awareness 
about HHMs’ compliance rate to vaccination programs 
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and orient them in a positive approach towards vaccina-
tion in Sardinia. 
Methods
In March 2013, we enrolled by both phone and a writ-
ten questionnaire sent by e-mail the 32 HHM of all Sar-
dinia hospitals which have totally 5,650 beds serving the 
whole Sardinia population (1.600.000 inhabitants).
A self-reported structured form was completed by 
HHMs. In case of lacking or inadequate response HHMs 
were successively contacted by phone to complete infor-
mation. According to some critical aspects highlighted in 
2010 by a team of occupational physicians of the Italian 
Society of Occupational Health and Industrial Hygiene 
(SIMLII), the questionnaire included 10 items based on 
multiple-choice questions. Each hospital was allowed to 
mark more than one answer per item.
The study investigated about the immunological pattern 
of HCWs towards Influenza, hepatitis  B (HB), mea-
sles-mumps-rubella (MMR), varicella and tuberculosis 
(TBC). Furthermore, information was collected about 
the performed educational campaign for influenza vac-
cination. Specifically, five questions concerned flu vac-
cination and investigated (a) effective accomplishment 
of the educational campaign on vaccination and its start-
ing, (b) the campaign planners, (c) the different strate-
gies used to inform health professionals about the oppor-
tunity to undergo vaccination, (d) the topics used dur-
ing the campaign, and (e) available data on vaccination 
coverage. One question regarded HB vaccination and 
the gathered data about compliance to vaccination. Two 
questions were addressed to serological surveillance: the 
first one asked whether serological tests for detection of 
MMR and Varicella viruses’ antibodies were included in 
routine surveillance of HCWs by Occupational Health 
Physicians. The other one asked whether serological re-
sults were collected. The last two questions concerned 
TBC: one investigated whether and in which occasions 
HCWs underwent Mantoux skin test, the other one de-
tected whether Mantoux was replaced or integrated by 
“in vitro” test.
The results were returned to each HHM in order to pro-
vide them a comparison with the other hospitals. In addi-
tion, we suggested recommendations about vaccination 
in HCWs according to National laws and National and 
International scientific communities.
Results
Out of the 32 hospitals enrolled in the study, 30 joined 
our survey (94% compliance): three were University 
Hospitals and 27 were General Hospitals. The two non-
responding hospitals were long-term care institutes. The 
total number of HCWs of the 30 hospitals was 12,977. 
Among these, 26% were medical staff, 47% nurses, and 
27% represented other hospital staff.
Influenza
Twenty-five out of the 30 hospitals (77%) accomplished 
the vaccination campaign against flu carried out between 
October and December 2011, particularly November, in 
18 hospitals. 
All the hospitals answered to the questions concerning 
the communication methods during the flu campaign: 
18  hospitals (72%) informed HCWs about the chance 
to be vaccinated by newsletter to unit managers, nursing 
and technicians coordinator, 8 (32%) sending newslet-
ter to unit managers only, 7 (28%) through active call, 2 
(8%) using posters and advertising. 
Fig. 1. Influenza vaccination coverage rate in HCWs of 23 Sardinia Hospitals.
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The coordination of the campaign was performed 
by HHM in 20  hospitals (80%), by Health visitors 
in 8  (32%) and by Occupational Health Physicians in 
7 hospitals (28%). In 8 (32%) hospitals the Prevention 
Department managed the campaign. Therefore different 
professionals were involved in managing and coordinat-
ing the campaign in the different hospitals at the same 
time. This heterogeneity may depend on the hospital 
characteristics in terms of structure, complexity, size, 
and (urban or rural) area.
Concerning the topics used during the vaccination cam-
paign to inform HCWs all 25 hospitals enlightened 
about professional and social responsibility in patients’ 
protection; 20  reported also efficacy and safety of the 
vaccine and 17 warned about the frequency and severity 
of influenza. 
Data of vaccination coverage among HCWs were report-
ed only by 23 hospitals. The coverage rate is shown in 
Figure 1; 74% of the hospitals indicated a coverage rate 
lower than 10%. 
Hepatitis B
Data on immunization coverage were available in 14 of 
30 hospitals (Fig. 2). Regional average was 76%; 5 hos-
pitals were below the average and 9 were above, only 
one hospital had 92% vaccination coverage.  Antibody 
assay (anti-HBs) was carried out in all the 30 respondent 
hospitals but only 14 had electronically collected data.
Varicella, Measles, Mumps, Rubella
Most hospitals did not perform serological tests to detect 
antibodies against Varicella, Measles, Mumps and Ru-
bella viruses in HCWs.
Three (10%) hospitals applied health surveillance for 
those viruses and other two hospitals performed sero-
logical test for Rubella in higher risk occupational cat-
egories.
No hospital had available data on immunity to those in-
fections.
Tuberculosis
Intradermal Mantoux test was used in 29 of 30 hospi-
tals: in 32% of hospitals HCWs were submitted to the 
Mantoux test at the hiring time and/or in post exposure 
situations.
In 1 hospital, Mantoux test was replaced by “in vitro” 
test (Quantiferon) and in 20 hospitals Quantiferon inte-
grated Mantoux test.
Discussion
Vaccination is an important prophylactic action to re-
duce the number of susceptible HCWs and to indirectly 
protect susceptible patients and colleagues  [7]. An ad-
ditional benefit is a reduction in work time lost due to 
illness. Despite the persistence of outbreaks of vaccine-
preventable diseases in health care facilities, HCWs vac-
cination rates remain suboptimal globally. Higher vacci-
nation coverages among HCWs than the actual would be 
useful both to reinforce occupational safety in health care 
facilities and to prevent nosocomial outbreaks [1, 8, 9].
The Italian Health Ministry recommends HCWs to un-
dergo vaccinations (i.e. anti-hepatitis  B, anti-flu, anti-
measles-mumps-rubella, varicella, anti-pertussis and, 
when indicated, anti-tuberculosis) not only to reduce 
Fig. 2. Immunization coverage for Hepatitis B in 14 Sardinia Hospitals. 
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employees’ absenteeism that may increase workload 
for staff, but also to prevent the nosocomial infection 
risk, especially in elderly or immunocompromised 
patients  [6]. The same Institution have also included 
among the new objectives of the National Prevention 
Plan 2014-2018 an increasing vaccination coverage for 
both general and high-risk population including HCWs, 
by looking for a cooperation between regions in which 
regions more experienced can support regions with the 
lowest vaccination coverage [10].
Several outbreaks of health care facility-acquired influ-
enza, including immunosuppressed or old patients, have 
been documented as a consequence of low vaccine effec-
tiveness, thus requiring consequently an indirect protec-
tion. Influenza vaccination of all HCWs is recommend-
ed by the World Health Organization (WHO), [11] US 
Centers for Disease Control and Prevention (CDC) [1], 
and by the Italian Ministry of Health [6] in order to pre-
vent transmission of influenza from HCWs to patients. 
Nevertheless, the same countries show a low uptake of 
influenza vaccine in HCWs [12]. A global literature re-
view on vaccination programs in HCWs reported a per-
centage of vaccination coverage ranging from 2.1% to 
82%, with highest uptake rates occurring in USA  [13] 
(from 40% to 87.4%)  [14,  15,  16,  17], followed by 
Germany (26.9%)  [18], and Spain (from 14.7% to 
38%) [19]. In Italy, data on vaccination coverage among 
HCWs are not regularly collected and the few ad-hoc 
studies have shown low coverage rates of 0-29%  [20], 
and 20.8% [21]. In the 2012-2013 season, the coverage 
rate for the working-age population was 10%  [22]. In 
our survey most of Sardinia hospitals had an influenza 
coverage rate lower than 6%.
Some studies highlighted how compulsory influenza 
vaccination with forfeit for non-adhesions was associat-
ed with larger compliance to vaccination programs [23]. 
Other authors asserted that voluntary vaccination of 
HCWs against influenza would represent the most effec-
tive strategy  [24]. Hospitals that used personal contact 
approach had higher vaccination rates [24, 25]. Differ-
ently, newsletters sent by HHM to unit managers, and 
both nurse and technician coordinators were the most 
frequent tool used by Sardinia hospitals. Nevertheless, 
this tool obtained a vaccination coverage lower than 
10% in 74% of the involved hospitals. A recent Italian 
study implemented different actions such as education, 
promotion, and easy access to staff vaccination in order 
to increase HCWs vaccination coverage  [26]. Despite 
these efforts, the results showed that the vaccination cov-
erage in the hospital staff was underperforming. On the 
light of these results, new techniques of information and 
empowerment on the importance of flu vaccination for 
HCWs should be considered and activated.
In 1997, CDC recommended HBV vaccination for all 
HCWs [27]; nevertheless, HBV vaccine coverage rate 
in USA was 63.4%, well below the 90% goal  [28]. 
Similar percentages were reported in other countries 
(85% for Belgium, 55.4% for India, and 55% for Mo-
rocco) [29, 30, 31].
In 1991, Italy introduced HBV mandatory vaccination 
for infants and 12-year-old adolescents until 2003 when 
the two cohorts joined together  [32]. In persons who 
received primary immunization in the first year of life, 
immune memory for HBsAg lasted for at least 17 years 
and additional booster doses were not needed to enhance 
long-term immunization  [33,  34,  35,  36]. In Italian 
HCWs who did not receive HBV vaccination as adoles-
cents and are older than 35-36 years, testing HCWs at 
hiring time and administering the vaccine to those who 
prove susceptible to HBV infection is strongly advised. 
In Italy, the coverage rate of HBV vaccination ranged 
from 43% to 87% [37]. Thus, we emphasize that efforts 
should be made to increase the number of vaccinated 
HCWs for HBV protection.
Measles, mumps, rubella, and varicella (MMRV) are 
highly contagious diseases, and pose a high risk for both 
HCWs and patients [2]. In Italy, the percentage of im-
munization in HCWs ranged from 85.7% to 95.1% for 
varicella, from 47% to 96.8% for rubella, from 71.4% 
to 97.8% for measles, and from 52.5% to 87.6% for 
mumps  [38, 39]. These results show a significant pro-
portion of unprotected workers. In fact, most of the 
Sardinia hospitals did not perform serological tests for 
MMVR on HCWs. 
Furthermore, tuberculosis still remains a severe world-
wide health problem, especially among immunocom-
promised patients. High percentage of latent Mycobac-
terium tuberculosis infection among HCWs and the in-
creasing number of Mycobacterial strains resistant to the 
main drug therapies increases the need for prevention 
programs health care workers.
Tuberculin skin test (TST) is still globally recommended 
to screen HCWs [40] despite its limitations. In effect, the 
need for a return visit to assess the test effect, often, re-
sults in a low compliance to follow-up [41]. These limits 
could be overtaken by advancement in the in vitro test, 
which detects the interferon-g production in response to 
other Mycobacterium tuberculosis antigens. QuantiFER-
ON-in tube test (QFT-in tube) does not need for a second 
visit to interpret results and it has a higher specificity 
than TST  [42]. An Australian study compared QFT-in 
tube test to the TST in HCWs. The results demonstrated 
that positive QFT-in tube test strongly correlated with 
risk factors for TB exposure more than positive TST, 
especially in a low tuberculosis prevalence population. 
Yet, a positive TST strongly correlated with a prior his-
tory of BCG vaccination [43]. 
The main limitation of the study regards the data 
collection method. Specifically, we have used a non-
validated questionnaire, which can result in a low 
level of reliability of the data. Furthermore, we did 
not examine the vaccination coverage according to 
the different occupational categories and healthcare 
settings. This did not allow us to identify specific 
professionals or healthcare areas that mainly need for 
specific intervention strategies to increase vaccina-
tion coverages.
Nevertheless, there are several advantages from this re-
search. The data from the whole Sardinia district have 
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shown in HHM a low level of awareness about HCWs 
vaccination. Furthermore, we have highlighted some 
critical aspects that can be considered by the local poli-
cy-makers to organize tailored preventive interventions. 
We, thus, emphasize the strong need to implement infor-
mation programs addressed to HCWs about vaccination-
preventable diseases for potentially spreading in hospital 
settings complying with a patient-centered care system. 
Another key-point of our study is a pragmatic low-budg-
et method to communicate with health managers; this 
method has allowed us to get a large amount of data in 
a small lapse of time, thus reducing costs. Finally, our 
study provides evidence for stimulating health managers 
of Sardinia about the need to identify HCWs susceptible 
to threats of some infectious diseases damaging the hos-
pital setting. This step is essential to achieve preventive 
strategies aimed to guarantee the health of both patients 
and HCWs.
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